Study Coordinator for NCT Phase I - Ester, United States - Cascade Innovations

Cascade Innovations
Cascade Innovations
Verified Company
Ester, United States

1 month ago

Meredith Sinclair

Posted by:

Meredith Sinclair

beBee Recruiter
Description


The University Hospital Heidelberg (UKHD) is one of the most important medical centers in Germany and is known for its development of innovative diagnostics and therapies, as well as their rapid implementation for the patient.

With around employees throughout the group in more than 50 clinical departments with over 2,500 beds, approximately patients are treated annually as inpatients and outpatients.



Study Coordinator for NCT Phase I - Early Clinical Studies Team (m/f/d)
Starting at the earliest possible date at the National Center for Tumor Diseases (NCT) Heidelberg for the Department of Medical Oncology - Phase I Study Secretariat.

The National Center for Tumor Diseases (NCT) Heidelberg is one of the leading oncological centers in Germany.

The founders and sponsors of the NCT are the German Cancer Research Center (DKFZ), the University Hospital Heidelberg, the Medical Faculty Heidelberg, and the German Cancer Aid.

The NCT Heidelberg's mission is to closely link research and patient care, with a special focus on patient-oriented, personalized cancer medicine.

The Department of Medical Oncology at the University Hospital Heidelberg treats both inpatients and outpatients with solid tumors. Through intensive research, the latest findings from basic research are translated into clinical practice. The focus is on the exploration of innovative
More jobs from Cascade Innovations
See all jobs of Cascade Innovations